• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Strategies for eradication in the year 2020.2020年的根除策略。
Saudi J Gastroenterol. 2020 Mar-Apr;26(2):63-65. doi: 10.4103/sjg.SJG_95_20.
2
Helicobacter pylori eradication for functional dyspepsia: what are we treating?: comment on "Helicobacter pylori eradication in functional dyspepsia".根除幽门螺杆菌治疗功能性消化不良：我们在治疗什么？：对“根除幽门螺杆菌治疗功能性消化不良”的评论
Arch Intern Med. 2011 Nov 28;171(21):1936-7. doi: 10.1001/archinternmed.2011.541.
3
Comment to: "Different Antibiotic No Culture Eradication (DANCE) of Helicobacter pylori: an easy way to manage H. pylori eradication".对《幽门螺杆菌的不同抗生素无培养根除（DANCE）：一种管理幽门螺杆菌根除的简便方法》的评论
Dig Liver Dis. 2013 May;45(5):438. doi: 10.1016/j.dld.2012.12.015. Epub 2013 Jan 29.
4
[Failure in the eradication of Helicobacter pylori: the role of antibiotic resistance].[幽门螺杆菌根除失败：抗生素耐药性的作用]
Orv Hetil. 2005 May 1;146(18):839-42.
5
Eradication therapy for Helicobacter pylori.幽门螺杆菌根除治疗
Gastroenterology. 2007 Sep;133(3):985-1001. doi: 10.1053/j.gastro.2007.07.008.
6
[Therapeutics of infection by Helicobacter pylori in 2008].《2008年幽门螺杆菌感染的治疗方法》
Rev Gastroenterol Mex. 2008;73(2):93-105.
7
Eradication rate of Helicobacter pylori reinfection in Korea: A retrospective study.韩国幽门螺杆菌再感染的根除率：一项回顾性研究。
J Gastroenterol Hepatol. 2019 Oct;34(10):1696-1702. doi: 10.1111/jgh.14639. Epub 2019 Mar 14.
8
[Effect of Helicobacter pylori eradication on patients with functional dyspepsia].幽门螺杆菌根除对功能性消化不良患者的影响
Rev Esp Enferm Dig. 2008 Sep;100(9):532-9. doi: 10.4321/s1130-01082008000900002.
9
[Treatment for the eradication of Helicobacter pylori. Recommendations of the Spanish Consensus Conference].[根除幽门螺杆菌的治疗。西班牙共识会议的建议]
Med Clin (Barc). 2000 Feb 12;114(5):185-95. doi: 10.1016/s0025-7753(00)71237-1.
10
Primary and secondary treatment for Helicobacter pylori in the United States.美国幽门螺杆菌的初级和二级治疗
Rev Gastroenterol Disord. 2005 Spring;5(2):67-72.

引用本文的文献

1
The Efficacy of Quadruple Therapy Versus Triple Therapy in Helicobacter pylori Eradication.四联疗法与三联疗法根除幽门螺杆菌的疗效比较
Cureus. 2025 Apr 14;17(4):e82255. doi: 10.7759/cureus.82255. eCollection 2025 Apr.
2
The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance.在抗生素耐药性不断变化的情况下，含铋四联疗法与非铋四联疗法治疗一线抗幽门螺杆菌治疗的疗效在 4 年时间间隔内的比较。
Biomed J. 2021 Dec;44(6 Suppl 2):S275-S281. doi: 10.1016/j.bj.2020.11.012. Epub 2020 Nov 24.
3
Rescue effects of -containing bismuth regimens after treatment failure.含铋剂方案在治疗失败后的挽救效果。
New Microbes New Infect. 2021 May 19;42:100904. doi: 10.1016/j.nmni.2021.100904. eCollection 2021 Jul.
4
An Innovative Approach to Control -Induced Persistent Inflammation and Colonization.一种控制诱导性持续性炎症和定植的创新方法。
Microorganisms. 2020 Aug 10;8(8):1214. doi: 10.3390/microorganisms8081214.

本文引用的文献

1
Efficacy of a bismuth-based quadruple therapy regimen for eradication in Saudi Arabia.在沙特阿拉伯，铋剂四联疗法根除的疗效。
Saudi J Gastroenterol. 2020 Mar-Apr;26(2):84-88. doi: 10.4103/sjg.SJG_626_19.
2
Treatment with compound Lactobacillus acidophilus followed by a tetracycline- and furazolidone-containing quadruple regimen as a rescue therapy for Helicobacter pylori infection.采用复方嗜酸乳杆菌治疗，随后使用包含四环素和呋喃唑酮的四联疗法作为幽门螺杆菌感染的补救治疗。
Saudi J Gastroenterol. 2020 Mar-Apr;26(2):78-83. doi: 10.4103/sjg.SJG_589_19.
3
Efficacy of Lactobacillus-supplemented triple therapy for H. pylori eradication: A meta-analysis of randomized controlled trials.含益生菌三联疗法根除幽门螺杆菌的疗效：一项随机对照试验的荟萃分析。
PLoS One. 2019 Oct 2;14(10):e0223309. doi: 10.1371/journal.pone.0223309. eCollection 2019.
4
Helicobacter pylori: molecular basis for colonization and survival in gastric environment and resistance to antibiotics. A short review.幽门螺杆菌：在胃环境中定植和生存以及对抗生素耐药的分子基础。简短综述。
Infect Dis (Lond). 2019 Jun;51(6):399-408. doi: 10.1080/23744235.2019.1588472. Epub 2019 Mar 25.
5
Benign and malignant gastroduodenal diseases associated with Helicobacter pylori: a narrative review and personal remarks in 2018.与幽门螺杆菌相关的胃十二指肠良性和恶性疾病：2018年的叙述性综述及个人评论
Minerva Gastroenterol Dietol. 2018 Sep;64(3):280-296. doi: 10.23736/S1121-421X.18.02481-9. Epub 2018 Feb 19.
6
First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy.黎巴嫩幽门螺杆菌的一线治疗：含铋四联疗法与 14 天序贯疗法的比较。
Microb Pathog. 2018 Apr;117:23-26. doi: 10.1016/j.micpath.2018.02.010. Epub 2018 Feb 8.
7
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.发现、研究和开发新抗生素：世界卫生组织抗微生物药物耐药性和结核病优先病原体清单。
Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21.
8
New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice.幽门螺杆菌感染患者的新型含铋四联疗法：意大利临床实践的首次经验。
Helicobacter. 2017 Jun;22(3). doi: 10.1111/hel.12371. Epub 2017 Jan 26.
9
A 2016 panorama of Helicobacter pylori infection: key messages for clinicians.2016年幽门螺杆菌感染全景：给临床医生的关键信息
Panminerva Med. 2016 Dec;58(4):304-317.
10
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 V/佛罗伦萨共识报告。
Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.

Strategies for eradication in the year 2020.

作者信息

Pellicano Rinaldo, Ribaldone Davide Giuseppe, Caviglia Gian Paolo

机构信息

Unit of Gastroenterology Molinette Hospital, University of Turin, Turin, Italy.

Unit of Gastroenterology Molinette Hospital; Department of Medical Sciences, University of Turin, Turin, Italy.

出版信息

Saudi J Gastroenterol. 2020 Mar-Apr;26(2):63-65. doi: 10.4103/sjg.SJG_95_20.

DOI:10.4103/sjg.SJG_95_20
PMID:32295934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7279073/
Abstract
摘要